Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0602-2026

BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit) Recall

BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)

FDA recall Class II

Ongoing

FDA lists this Class II recall for BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit). Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0602-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 22, 2025
FDA report date
Dec 3, 2025
Quantity in commerce
97 Kits (2,910 pouches)
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)

Affected model & UDI checker

Search the exact identifiers published for Z-0602-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
423742BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)Check source noticeNot specified
Not specifiedBioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)Check source notice00815381020529
FDA code information

UDI: 00815381020529 /Lot # 2649724 Expanded Lot#: 1471725

View the original FDA recall notice

Why was this product recalled?

Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Biofire Diagnostics, LLC take?

On May 28, 2026, Biomerieux issued a "Urgent: Medical Device Recall" Expansion Notification to affected consignees via E-Mail. Initial notification was sent out on October 22, 2025. Biomerieux asked consignees to take the following actions: 1. Examine your inventory for the lot identified in this field safety notice. 2. Discontinue use and discard any remaining product from this lot in your possession. 3. Please confirm the quantity of kits that have been destroyed, previously used, or returned on the attached Acknowledgement of Receipt Form. 4. If you have further distributed this product, please identify any recipients and notify them at once. 5. Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification. 6. Complete and submit the report online. Regular Mail or Fax: Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form or submit by fax to 1-800-FDA-0178.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology